PMID- 15579451 OWN - NLM STAT- MEDLINE DCOM- 20050111 LR - 20181113 IS - 0002-9440 (Print) IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 165 IP - 6 DP - 2004 Dec TI - Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. PG - 2087-98 AB - Thrombospondin 2 (TSP2), a matricellular protein with a primary role in modulating cell-matrix interactions, has been implicated in tissue repair and foreign body responses. Here we show that TSP2 has regulatory function in the chronic inflammatory lesions of rheumatoid arthritis. Tissue TSP2, produced by synovial fibroblasts, endothelial cells, and macrophages correlated not only with the intensity of angiogenesis but also with the architecture of lymphoid infiltrates. Synovial tissues with diffuse inflammatory infiltrates had high levels of TSP2, whereas synovial tissues with ectopic germinal center reactions and T cell-B cell aggregates produced low levels. Cell-based gene therapy with TSP2 was used to examine the in vivo effects of the matrix protein on neoangiogenesis and lymphoid organization. Human synovium-severe combined immunodeficiency (SCID) mouse chimeras were treated with TSP2-transfected fibroblasts deposited into the peritoneum. Overexpression of TSP2 led to the accumulation of TSP2 protein in the inflamed synovium and resulted in a prompt inhibition of lesional vascularization. Beside its anti-angiogenic activity, TSP2 also suppressed the production of the proinflammatory mediators, interferon-gamma and tumor necrosis factor-alpha, and induced the depletion of tissue-residing T cells. We propose that TSP2 is an endogenous regulator of angiogenesis and autoimmune inflammation in the synovium and represents a protective mechanism preventing ectopic lympho-organogenesis and persistent inflammation in this tissue site. FAU - Park, Yong Wook AU - Park YW AD - Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. FAU - Kang, Young Mo AU - Kang YM FAU - Butterfield, Joe AU - Butterfield J FAU - Detmar, Michael AU - Detmar M FAU - Goronzy, Jorg J AU - Goronzy JJ FAU - Weyand, Cornelia M AU - Weyand CM LA - eng GR - R01 AR 41974/AR/NIAMS NIH HHS/United States GR - R01 AI 44142/AI/NIAID NIH HHS/United States GR - R01 AR042527/AR/NIAMS NIH HHS/United States GR - R01 AI044142/AI/NIAID NIH HHS/United States GR - R01 AR041974/AR/NIAMS NIH HHS/United States GR - R01 EY 11916/EY/NEI NIH HHS/United States GR - R01 AR 42527/AR/NIAMS NIH HHS/United States GR - R01 EY011916/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (Thrombospondins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (thrombospondin 2) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - Arthritis, Rheumatoid/immunology/metabolism/*pathology MH - B-Lymphocytes/immunology/metabolism/pathology MH - Cells, Cultured MH - Endothelial Cells/immunology/metabolism/pathology MH - Fibroblasts/immunology/metabolism/pathology MH - Inflammation/immunology/metabolism/*pathology MH - Interferon-gamma/metabolism MH - Macrophages/immunology/metabolism/pathology MH - Mice MH - Mice, Inbred NOD MH - Mice, SCID MH - *Neovascularization, Pathologic MH - Peritoneum/immunology/metabolism/pathology MH - Synovial Membrane/cytology/immunology/metabolism MH - Synovitis/immunology/metabolism/pathology MH - T-Lymphocytes/immunology/metabolism/pathology MH - Thrombospondins/*pharmacology MH - Tumor Necrosis Factor-alpha/metabolism PMC - PMC1618704 EDAT- 2004/12/08 09:00 MHDA- 2005/01/12 09:00 PMCR- 2005/06/01 CRDT- 2004/12/08 09:00 PHST- 2004/12/08 09:00 [pubmed] PHST- 2005/01/12 09:00 [medline] PHST- 2004/12/08 09:00 [entrez] PHST- 2005/06/01 00:00 [pmc-release] AID - S0002-9440(10)63259-2 [pii] AID - 10.1016/S0002-9440(10)63259-2 [doi] PST - ppublish SO - Am J Pathol. 2004 Dec;165(6):2087-98. doi: 10.1016/S0002-9440(10)63259-2.